Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase

Detalhes bibliográficos
Autor(a) principal: Rossel,Carlos von Plessing
Data de Publicação: 2000
Outros Autores: Sepúlveda Carreño,Jacqueline, Rodríguez-Baeza,Mario, Alderete,Joel Bernabé
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Química Nova (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422000000600007
Resumo: Complexation between acyclovir (ACV), an antiviral drug used for the treatment of herpes simplex virus infection, and beta-cyclodextrin (beta-CD) was studied in solution and in solid states. Complexation in solution was evaluated using solubility studies and nuclear magnetic resonance spectroscopy (¹H-NMR). In the solid state, X-ray diffraction, differential scanning calorimetry (DSC), thermal gravimetric analysis (TGA) and dissolution studies were used. Solubility studies suggested the existence of a 1:1 complex between ACV and beta-CD. ¹H-NMR spectroscopy studies showed that the complex formed occurs with a stoichiometry ratio of 1:1. Powder X-ray diffraction indicated that ACV exists in a semicrystalline state in the complexed form with beta-CD. DSC studies showed the existence of a complex of ACV with beta-CD. The TGA studies confirmed the DSC results of the complex. Solubility of ACV in solid complexes was studied by the dissolution method and it was found to be much more soluble than the uncomplexed drug.
id SBQ-3_3678e21fae8c81b289c2d976ba671eef
oai_identifier_str oai:scielo:S0100-40422000000600007
network_acronym_str SBQ-3
network_name_str Química Nova (Online)
repository_id_str
spelling Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phasecyclodextrinacyclovirinclusion complexComplexation between acyclovir (ACV), an antiviral drug used for the treatment of herpes simplex virus infection, and beta-cyclodextrin (beta-CD) was studied in solution and in solid states. Complexation in solution was evaluated using solubility studies and nuclear magnetic resonance spectroscopy (¹H-NMR). In the solid state, X-ray diffraction, differential scanning calorimetry (DSC), thermal gravimetric analysis (TGA) and dissolution studies were used. Solubility studies suggested the existence of a 1:1 complex between ACV and beta-CD. ¹H-NMR spectroscopy studies showed that the complex formed occurs with a stoichiometry ratio of 1:1. Powder X-ray diffraction indicated that ACV exists in a semicrystalline state in the complexed form with beta-CD. DSC studies showed the existence of a complex of ACV with beta-CD. The TGA studies confirmed the DSC results of the complex. Solubility of ACV in solid complexes was studied by the dissolution method and it was found to be much more soluble than the uncomplexed drug.Sociedade Brasileira de Química2000-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422000000600007Química Nova v.23 n.6 2000reponame:Química Nova (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.1590/S0100-40422000000600007info:eu-repo/semantics/openAccessRossel,Carlos von PlessingSepúlveda Carreño,JacquelineRodríguez-Baeza,MarioAlderete,Joel Bernabéeng2001-01-18T00:00:00Zoai:scielo:S0100-40422000000600007Revistahttps://www.scielo.br/j/qn/ONGhttps://old.scielo.br/oai/scielo-oai.phpquimicanova@sbq.org.br1678-70640100-4042opendoar:2001-01-18T00:00Química Nova (Online) - Sociedade Brasileira de Química (SBQ)false
dc.title.none.fl_str_mv Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase
title Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase
spellingShingle Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase
Rossel,Carlos von Plessing
cyclodextrin
acyclovir
inclusion complex
title_short Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase
title_full Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase
title_fullStr Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase
title_full_unstemmed Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase
title_sort Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase
author Rossel,Carlos von Plessing
author_facet Rossel,Carlos von Plessing
Sepúlveda Carreño,Jacqueline
Rodríguez-Baeza,Mario
Alderete,Joel Bernabé
author_role author
author2 Sepúlveda Carreño,Jacqueline
Rodríguez-Baeza,Mario
Alderete,Joel Bernabé
author2_role author
author
author
dc.contributor.author.fl_str_mv Rossel,Carlos von Plessing
Sepúlveda Carreño,Jacqueline
Rodríguez-Baeza,Mario
Alderete,Joel Bernabé
dc.subject.por.fl_str_mv cyclodextrin
acyclovir
inclusion complex
topic cyclodextrin
acyclovir
inclusion complex
description Complexation between acyclovir (ACV), an antiviral drug used for the treatment of herpes simplex virus infection, and beta-cyclodextrin (beta-CD) was studied in solution and in solid states. Complexation in solution was evaluated using solubility studies and nuclear magnetic resonance spectroscopy (¹H-NMR). In the solid state, X-ray diffraction, differential scanning calorimetry (DSC), thermal gravimetric analysis (TGA) and dissolution studies were used. Solubility studies suggested the existence of a 1:1 complex between ACV and beta-CD. ¹H-NMR spectroscopy studies showed that the complex formed occurs with a stoichiometry ratio of 1:1. Powder X-ray diffraction indicated that ACV exists in a semicrystalline state in the complexed form with beta-CD. DSC studies showed the existence of a complex of ACV with beta-CD. The TGA studies confirmed the DSC results of the complex. Solubility of ACV in solid complexes was studied by the dissolution method and it was found to be much more soluble than the uncomplexed drug.
publishDate 2000
dc.date.none.fl_str_mv 2000-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422000000600007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422000000600007
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0100-40422000000600007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Química
publisher.none.fl_str_mv Sociedade Brasileira de Química
dc.source.none.fl_str_mv Química Nova v.23 n.6 2000
reponame:Química Nova (Online)
instname:Sociedade Brasileira de Química (SBQ)
instacron:SBQ
instname_str Sociedade Brasileira de Química (SBQ)
instacron_str SBQ
institution SBQ
reponame_str Química Nova (Online)
collection Química Nova (Online)
repository.name.fl_str_mv Química Nova (Online) - Sociedade Brasileira de Química (SBQ)
repository.mail.fl_str_mv quimicanova@sbq.org.br
_version_ 1750318101662007296